Radcliffe Capital Management’s Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CSTA.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTA.WS
SCM
HCM
MCM
PC
SBLIC
SCM
AC
SC
Radcliffe Capital Management's CSTA.WS Position: Q4 2023 in Review
Radcliffe Capital Management sold out of Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CSTA.WS) in Q4 2023, closing a stake of 135,566 shares — an estimated $3.8K sold.
Radcliffe Capital Management first reported a position in CSTA.WS in Q2 2021 and held it in 10 quarters. The position peaked at $1.37M in Q4 2022. 41 funds tracked by Wall St. Rank hold CSTA.WS as of Q4 2023.
- Radcliffe Capital Management reported no remaining Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
- Radcliffe Capital Management sold 135,566 Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2023, an estimated $3.8K.
- Radcliffe Capital Management first reported a position in Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 10 quarters.
- Radcliffe Capital Management's Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1.37M in Q4 2022.
- 41 funds tracked by Wall St. Rank held Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2023.
Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.